Cargill’s Animal Nutrition business and Purac, a subsidiary of CSM, announce their
collaboration in the development and commercialization of bio-based animal feed solutions.
These solutions promote stronger growth and better feed conversion in suboptimal
conditions in poultry production while at the same time have the potential to significantly
reduce the usage of antibiotics. A first commercial product, Aloapur®, will reach the market
in July of this year.
Under the collaboration, Purac, world market leader in lactic acid and lactic acid derivatives, is
focusing on technology development and production of Aloapur®, while Cargill Animal Nutrition’s
Provimi business, a leading global premix, specialties and feed additives supplier, is focused on
application development and commercialization of the product.
Aloapur®, a bio based animal feed solution for the improvement of the general health of animals,
has been developed and patented by Purac. Aloapur® is based on Lactylates and has been
developed for the first time in animal nutrition and has demonstrated to significantly improve growth
and feed conversion in poultry and turkey production in particular in suboptimal conditions. The
efficacy of Aloapur® has been extensively tested and demonstrated in both scientific research as
well as actual production farms by Purac and Cargill.
Commercial production will start in July in a newly built production facility at the Purac site in
Gorinchem, the Netherlands.
Cargill brings its animal nutrition expertise and global footprint to the partnership. Cargill’s Provimi
business will develop the application and offer Aloapur® to customers to help them improve animal
health and nutrition. Cargill Animal Nutrition is committed to selecting and developing innovative
solutions that can significantly improve animal nutrition.
Marco Bootz, Vice President Chemical & Pharma at Purac, comments: "CSM is developing into a
leading provider of bio-based ingredients and solutions. Our collaboration with Cargill is fully in line
with our strastrategy to develop commercially attractive bio-based alternatives using renewable and
sustainable resources. This new technology, Aloapur®, for animal health is based on our core
competence in lactic acid derivatives and emulsifiers. We believe that this technology has the
potential to significantly reduce the usage of low dosage antibiotics as growth promoters in animal
feed, without negatively impacting production. Cargill, the world leader in animal feed, will market